- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00533208
MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)
December 21, 2015 updated by: Merck Sharp & Dohme LLC
To assess the efficacy of MK0524 on seasonal allergies.
Study Overview
Study Type
Interventional
Enrollment (Actual)
766
Phase
- Phase 2
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Person has had at least 2 years of seasonal allergies
- Person has had a positive skin test to at least 1 of the allergens of the season
- Person is a non-smoker
Exclusion Criteria:
- Person has been hospitalized within the last 4 weeks
- Person is a female who has had a baby within the last 8 weeks or is still breast-feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2003
Primary Completion (Actual)
October 1, 2003
Study Completion (Actual)
October 1, 2003
Study Registration Dates
First Submitted
September 19, 2007
First Submitted That Met QC Criteria
September 19, 2007
First Posted (Estimate)
September 21, 2007
Study Record Updates
Last Update Posted (Estimate)
December 22, 2015
Last Update Submitted That Met QC Criteria
December 21, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0524-005
- 2007_616
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Seasonal Allergies
-
Labo'LifeCompletedSeasonal AllergyBelgium
-
Stallergenes GreerQuintiles, Inc.; Cenduit LLC; Aptuit Inc.; PHT CorporationCompletedHypersensitivity | Allergic Rhinitis | Allergic Conjunctivitis | Seasonal AllergyCzech Republic, Denmark, Estonia, Finland, France, Germany, Latvia, Lithuania, Poland, Slovakia, Sweden
-
University of FloridaWakunaga Pharmaceutical Co., Ltd.Completed
-
Alcon ResearchCompleted
-
Aldeyra Therapeutics, Inc.CompletedAllergic Conjunctivitis | Seasonal AllergiesCanada
-
University of Colorado, DenverNational Institutes of Health (NIH)RecruitingPeanut Allergies | Tree Nut Allergies | Other Food AllergiesUnited States
-
University Hospital, Strasbourg, FranceRecruiting
-
University of British ColumbiaCompleted